{
    "clinical_study": {
        "@rank": "161599", 
        "acronym": "ADJUNCT TWO\u2122", 
        "arm_group": [
            {
                "arm_group_label": "Liraglutide 1.8 mg + insulin", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Liraglutide 1.2 mg + insulin", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Liraglutide 0.6 mg + insulin", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Liraglutide placebo 0.3 ml + insulin", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "Liraglutide placebo 0.2 ml + insulin", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "Liraglutide placebo 0.1 ml + insulin", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This trial is conducted in Africa, Europe and North America. The purpose of the trial is to\n      investigate the efficacy and safety of liraglutide adjunct to insulin treatment in type 1\n      diabetes."
        }, 
        "brief_title": "The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diabetes", 
            "Diabetes Mellitus, Type 1"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Informed consent obtained before any trial-related activities. Trial-related\n             activities are any procedures that are carried out as part of the trial, including\n             activities to determine suitability for the trial\n\n          -  Male or female, aged equal to or greater than 18 years at the time of signing\n             informed consent\n\n          -  Type 1 diabetes mellitus (as diagnosed clinically) 12 months or longer prior to Visit\n             1 (i.e. screening)\n\n          -  Treatment with basal bolus or CSII (continuous subcutaneous insulin infusion, insulin\n             pump) treatment 6 months or longer prior to Visit 1 (i.e. screening)\n\n          -  Stable insulin treatment 3 months or longer prior to Visit 1 (i.e. screening), as\n             judged and documented by the investigator\n\n          -  HbA1c 7.0-10.0 percent (Diabetes Control and Complications Trial (DCCT)), both\n             inclusive, by central laboratory analysis (Visit 1, screening) corresponding to 53-86\n             mmol/mol (International Federation of Clinical Chemistry (IFCC))\n\n        Exclusion Criteria:\n\n          -  Prior use of glucagon-like peptide-1 (GLP-1) receptor agonist or dipeptidyl peptidase\n             IV (DPPIV) inhibitors\n\n          -  Use of any medication, which in the investigator's opinion could interfere with the\n             glycaemic control (e.g. systemic corticosteroids, pramlintide (Symlin\u00ae)) or affect\n             the subject's safety. Premix insulin is not allowed\n\n          -  Known proliferative retinopathy or maculopathy requiring acute treatment\n\n          -  Severe neuropathy, in particular autonomic neuropathy, i.e. gastroparesis, as judged\n             by the investigator\n\n          -  Uncontrolled/untreated blood pressure at screening (Visit 1) (after resting for 5\n             minutes) while sitting greater than 160 mmHg for systolic or greater than 100 mmHg\n             for diastolic (repeated measurement at Visit 2 (prior to performing the trial related\n             activities) is allowed to exclude white-coat hypertension)\n\n          -  History of acute or chronic pancreatitis\n\n          -  Screening (Visit 1) calcitonin value equal to or greater than 50 ng/L"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "804", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 25, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02098395", 
            "org_study_id": "NN9211-4083", 
            "secondary_id": [
                "2012-005778-74", 
                "U1111-1138-0619"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Liraglutide 1.8 mg + insulin", 
                "description": "Subjects randomised to 1.8 mg liraglutide treatment as an add-on to their pre-trial insulin treatment will receive 0.6 mg liraglutide for 2 weeks followed by 1.2 mg liraglutide for 2 weeks. After 4 weeks of treatment subjects will receive 1.8 mg liraglutide for 22 weeks. Administered subcutaneously (s.c., under the skin) once daily.", 
                "intervention_name": "liraglutide", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Liraglutide 1.2 mg + insulin", 
                "description": "Subjects randomised to 1.2 mg liraglutide treatment as an add-on to their pre-trial insulin treatment will receive 0.6 mg liraglutide for 2 weeks followed by 1.2 mg liraglutide for for 24 weeks. Administered subcutaneously (s.c., under the skin) once daily.", 
                "intervention_name": "liraglutide", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Liraglutide 0.6 mg + insulin", 
                "description": "Subjects randomised to 0.6 mg liraglutide treatment as an add-on to their pre-trial insulin treatment will remain on this dose throughout the trial (26 weeks). Administered subcutaneously (s.c., under the skin) once daily.", 
                "intervention_name": "liraglutide", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Liraglutide placebo 0.3 ml + insulin", 
                "description": "Subjects randomised to 0.3 mL liraglutide placebo as an add-on to their pre-trial insulin treatment will receive 0.1 mL for 2 weeks followed by 0.2 mL for 2 weeks. After 4 weeks of liraglutide placebo, subjects will receive 0.3 mL for 22 weeks. Administered subcutaneously (s.c., under the skin) once daily.", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Liraglutide placebo 0.2 ml + insulin", 
                "description": "Subjects randomised to 0.2 mL liraglutide placebo as an add-on to their pre-trial insulin treatment will receive 0.1 mL for 2 weeks followed by 0.2 mL for 24 weeks. Administered subcutaneously (s.c., under the skin) once daily.", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Liraglutide placebo 0.1 ml + insulin", 
                "description": "Subjects randomised to 0.1 mL liraglutide placebo as an add-on to their pre-trial insulin treatment will remain on this dose throughout the trial (26 weeks). Administered subcutaneously (s.c., under the skin) once daily.", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Insulin", 
                "Glucagon-Like Peptide 1"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 30, 2014", 
        "link": {
            "description": "Clinical Trials at Novo Nordisk", 
            "url": "http://novonordisk-trials.com"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72205"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chino", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91710"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Escondido", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92026"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Ramon", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94583"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Walnut Creek", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94598"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Golden", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80401"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30318"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roswell", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30076"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Champaign", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "61820"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Council Bluffs", 
                        "country": "United States", 
                        "state": "Iowa", 
                        "zip": "51501-3605"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rockville", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "20852"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55416-2699"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chesterfield", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63017"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Billings", 
                        "country": "United States", 
                        "state": "Montana", 
                        "zip": "59101"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Butte", 
                        "country": "United States", 
                        "state": "Montana", 
                        "zip": "59701"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albany", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "12206"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Staten Island", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10301"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Morehead City", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28557"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bristol", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37620-7352"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chattanooga", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37411"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amarillo", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "79106"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78758"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78731"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75230"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75230-6850"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Murray", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84123"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ogden", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84405"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Federal Way", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98003"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Renton", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98057"
                    }, 
                    "name": "Novo Nordisk Clinical Trial Call Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wien", 
                        "country": "Austria", 
                        "zip": "1130"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1090"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sofia", 
                        "country": "Bulgaria", 
                        "zip": "1431"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Halifax", 
                        "country": "Canada", 
                        "state": "Nova Scotia", 
                        "zip": "B3H 2Y9"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "K\u00f8benhavn", 
                        "country": "Denmark", 
                        "zip": "2400"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jyv\u00e4skyl\u00e4", 
                        "country": "Finland", 
                        "zip": "40620"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pierre-B\u00e9nite", 
                        "country": "France", 
                        "zip": "69495"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palermo", 
                        "country": "Italy", 
                        "zip": "90127"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Den Haag", 
                        "country": "Netherlands", 
                        "zip": "2597 AX"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cape Town", 
                        "country": "South Africa", 
                        "state": "Western Cape", 
                        "zip": "7925"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41014"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Link\u00f6ping", 
                        "country": "Sweden", 
                        "zip": "582 16"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Austria", 
                "Belgium", 
                "Bulgaria", 
                "Canada", 
                "Denmark", 
                "Finland", 
                "France", 
                "Italy", 
                "Netherlands", 
                "South Africa", 
                "Spain", 
                "Sweden"
            ]
        }, 
        "number_of_arms": "6", 
        "official_title": "A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial", 
        "overall_contact": {
            "email": "clinicaltrials@novonordisk.com", 
            "last_name": "Novo Nordisk"
        }, 
        "overall_official": {
            "affiliation": "Novo Nordisk A/S", 
            "last_name": "Global Clinical Registry (GCR, 1452)", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Canada: Health Canada", 
                "South Africa: Medicines Control Council", 
                "Austria: Agency for Health and Food Safety", 
                "Bulgaria: Bulgarian Drug Agency", 
                "Belgium: Federal Agency for Medicines and Health Products, FAMHP", 
                "Denmark: Danish Medicines Agency", 
                "Finland: Finnish Medicines Agency", 
                "France: Ministry of Health", 
                "Netherlands: Dutch Health Care Inspectorate", 
                "Italy: The Italian Medicines Agency", 
                "Spain: Spanish Agency of Medicines", 
                "Sweden: Medical Products Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in glycosylated haemoglobin (HbA1c)", 
            "safety_issue": "No", 
            "time_frame": "Week 0, Week 26"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02098395"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in body weight", 
                "safety_issue": "No", 
                "time_frame": "Week 0, Week 26"
            }, 
            {
                "measure": "Number of treatment-emergent symptomatic hypoglycaemic episodes", 
                "safety_issue": "No", 
                "time_frame": "Weeks 0-26"
            }
        ], 
        "source": "Novo Nordisk A/S", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novo Nordisk A/S", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}